SP Angel has reinforced its confidence in Atome Energy plc, highlighting the company's notable strides in the green energy sector, particularly the significant progress in its Paraguayan operations.
“The management team at ATOME have moved quickly in the first 24 months since the Company’s IPO to add tangible value to the project pipeline,” said analysts.
Scancell Holdings PLC (AIM:SCLP, OTC:SCNLF) has received the go-ahead from UK medical regulator MHRA to add another group of patients to its ongoing SCOPE skin cancer trial.
This third cohort will comprise 43 advanced unresectable melanoma patients who will receive Scancell’s iSCIB1+ with doublet therapy, consisting of existing blockbuster cancer treatments ipilimumab (Yervoy) plus nivolumab (Opdivo).
Shares in Oxford BioDynamics PLC (AIM:OBD) tumbled 23% to 26p, wiping out gains made in the past week, after it published results that were in line with most expectations.
The company, which has developed the EpiSwitch non-invasive screening tests, raised a total of £15.4 million before costs in the year ended 30 September 2023 in two equity fundraisings. Cash stood at £5.3 million at the end of September.
Tirupati Graphite has raised £1 million gross through a private placing at 11p per share, a discount of 8.33% to the closing mid-market price yesterday.
In addition, directors and other creditors have agreed to take shares instead of fees and salaries totalling £623,000.
Arrow Exploration Corp (TSX-V:AXL, AIM:AXL, OTC:CSTPF) is counting down to the kick off at its drill programme for the Carrizales Norte (CN) 4 well in the Tapir block onshore Colombia.
Today, it told investors it has now commenced set up of the Petroworks 1500-horsepower rig and drilling is expected to start in late January.
Galliford Try Holdings PLC (LSE:GFRD) said trading has been ahead of expectations in the first six months of its financial year.
The construction group said it now expects full-year revenue to be roughly 5% ahead of current market forecasts, resulting in profit before tax also getting an equivalent boost.
Ariana Resources PLC (AIM:AAU) said the strong gold price meant 2023 was one of the best years ever for revenue from its Kiziltepe operation in Turkey.
In total, the mine produced and sold 17,683 ounces, generating gross revenues of US$39.2 million at a gold price of US$2,218/oz (including silver credits) with the average gold price received US$1,945/oz.
ATOME Energy PLC (AIM:ATOM), the only international green fertiliser project developer listed on the London Stock Exchange, has provided an encouraging update on its operations in Paraguay.
The Front-End Engineering Design (FEED) study and the Engineering, Procurement and Construction (EPC) of the Villeta Project are advancing well, with completion anticipated in the first quarter.
A drug candidate being developed by Poolbeg Pharma PLC (AIM:POLB, OTCQB:POLBF) has the potential to "revolutionise the impact of cancer immunotherapies", according to the company's chief business officer David Allmond.
POLB 001 has been identified to target cytokine release syndrome (CRS), induced by cancer immunotherapies.